This inventor holds 4 USPTO granted patents. Top assignees: Aventis Pharma Limited, Aventis Pharmaceuticals Inc., Axys Pharmaceuticals, Inc.. Active years: 2003-2006.
Location History:
- Brentwood, GB (2003 - 2004)
- West Malling, GB (2003 - 2006)
Company Filing History:
3 out of 39 
1 out of 207 
1 out of 40 Years Active: 2003-2006
Title: The Innovations of Stephen Dennis Pickett
Introduction
Stephen Dennis Pickett is a notable inventor based in Brentwood, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as therapeutic agents. With a total of 4 patents to his name, his work has had a meaningful impact on medical science.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Compounds and compositions as cathepsin inhibitors." This invention relates to novel selective cathepsin S inhibitors, including their pharmaceutically acceptable salts and N-oxides, along with their uses as therapeutic agents and the methods of their making. Another significant patent is "Substituted bicyclic heteroaryl compounds and their use as integrin antagonists," which showcases his innovative approach to drug development.
Career Highlights
Stephen has worked with prominent companies in the pharmaceutical industry, including Aventis Pharma Limited and Aventis Pharmaceuticals Inc. His experience in these organizations has allowed him to refine his skills and contribute to various projects that advance medical research.
Collaborations
Stephen has collaborated with notable professionals in his field, including David Edward Clark and Paul Robert Eastwood. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Stephen Dennis Pickett's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence the development of therapeutic agents that can improve health outcomes.